Nucleome Therapeutics has strengthened its intellectual property portfolio after the [...]
Nucleome Therapeutics has appointed Michelle Morrow as chief scientific officer, [...]
Nucleome Therapeutics has strengthened its intellectual property portfolio after the [...]
Nucleome Therapeutics has appointed Michelle Morrow as chief scientific officer, [...]